Skip to main content
. 2019 Nov 27;11(1):156–165. doi: 10.1111/1759-7714.13258

Figure 1.

Figure 1

Cell survival test of HCC827, PC9, HCC827‐Gef and PC9‐Gef. (a) The sensitivity of HCC827 and HCC827‐Gef cells to gefitinib was examined by CCK8 assay. (Inline graphic) HCC827 and (Inline graphic) HCC827‐Gef. (b) The sensitivity of PC9 and PC9‐Gef cells to gefitinib was examined by CCK8 assay. (Inline graphic) PC9 and (Inline graphic) PC9‐Gef.